Technical Analysis for SKYE - Skye Bioscience Inc

Grade Last Price % Change Price Change
D 0.0222 5.71% 0.0012
SKYE closed down 5.83 percent on Thursday, March 23, 2023, on 23 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 5.71%
Inside Day Range Contraction 5.71%
Wide Bands Range Expansion 5.71%
Oversold Stochastic Weakness 5.71%
Stochastic Buy Signal Bullish -0.45%
Doji - Bullish? Reversal -0.45%
Lower Bollinger Band Walk Weakness -0.45%
Wide Bands Range Expansion -0.45%
Lower Bollinger Band Touch Weakness -0.45%
Oversold Stochastic Weakness -0.45%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 5% about 2 hours ago
Up 3% about 2 hours ago
2x Volume Pace about 2 hours ago
1.5x Volume Pace about 2 hours ago
Down 3% about 3 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Skye Bioscience Inc Description

Skye Bioscience, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of cannabinoid-based therapeutics for unmet medical needs worldwide. The company's lead product candidate is NB1111, which is in preclinical trials for the treatment of glaucoma. It is also developing NB2222, a product candidate in preclinical trials for use in the treatment of various eye diseases, including uveitis, dry eye syndrome, macular degeneration, and diabetic retinopathy; and NB3111, a cannabinoid cocktail in testing for use as an anti-infective agent against various strains of antibiotic resistant bacteria, including methicillin-resistant Staphylococcus aureus. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. was founded in 2012 and is based in San Diego, California


Sector: Healthcare
Industry: Biotechnology
Keywords: Medical Specialties Clinical Medicine Biopharmaceutical Diabetes Ophthalmology Glaucoma Macular Degeneration Diabetic Retinopathy Retinopathy Blindness Uveitis Staphylococcus Aureus Eye Disease Eye Diseases

Is SKYE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 0.0595
52 Week Low 0.0105
Average Volume 1,898,574
200-Day Moving Average 0.0273
50-Day Moving Average 0.0291
20-Day Moving Average 0.0265
10-Day Moving Average 0.0240
Average True Range 0.0045
RSI 35.06
ADX 22.7
+DI 13.3333
-DI 21.9048
Chandelier Exit (Long, 3 ATRs) 0.0242
Chandelier Exit (Short, 3 ATRs) 0.0335
Upper Bollinger Bands 0.0332
Lower Bollinger Band 0.0198
Percent B (%b) 0.09
BandWidth 50.5660
MACD Line -0.0025
MACD Signal Line -0.0019
MACD Histogram -0.0007
Fundamentals Value
Market Cap 5.25 Million
Num Shares 250 Million
EPS 0.03
Price-to-Earnings (P/E) Ratio 0.84
Price-to-Sales 0.00
Price-to-Book 5.33
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0246
Resistance 3 (R3) 0.0247 0.0236 0.0240
Resistance 2 (R2) 0.0236 0.0227 0.0236 0.0238
Resistance 1 (R1) 0.0223 0.0221 0.0218 0.0222 0.0236
Pivot Point 0.0212 0.0212 0.0209 0.0212 0.0212
Support 1 (S1) 0.0199 0.0203 0.0194 0.0198 0.0184
Support 2 (S2) 0.0188 0.0197 0.0188 0.0182
Support 3 (S3) 0.0175 0.0188 0.0180
Support 4 (S4) 0.0174